Resultados de procura - Heinz Gisslinger

Limitar resultados
  1. 1
    Current and future treatment options for polycythemia vera

    Current and future treatment options for polycythemia vera por Martin Grießhammer, Heinz Gisslinger, Ruben A. Mesa

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Erythropoietin Treatment of Anemia Associated with Multiple Myeloma

    Erythropoietin Treatment of Anemia Associated with Multiple Myeloma por Heinz Ludwig, E. Fritz, H. Kotzmann, P Höcker, Heinz Gisslinger, Ursula Barnas

    Publicado 1990
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification

    Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification por Jürgen Thiele, Hans Michael Kvasnicka, Leonhard Müllauer, Veronika Buxhofer‐Ausch, Bettina Gisslinger, Heinz Gisslinger

    Publicado 2011
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera

    Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera por Raffaele Landolfi, Roberto Marchioli, Jack Kutti, Heinz Gisslinger, Gianni Tognoni, Carlo Patrono, Tiziano Barbui

    Publicado 2004
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Anagrelide for thrombocytosis in myeloproliferative disorders

    Anagrelide for thrombocytosis in myeloproliferative disorders por Michael Steurer, Guenther Gastl, Wieslaw‐Wiktor Jedrzejczak, Robert Pytlík, Werner Lin, Ernst Schlögl, Heinz Gisslinger

    Publicado 2004
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha

    Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha por Heinz Gisslinger, Bettina Gilly, W. Woloszczuk, Wolfgang R. Mayr, L Havelec, Werner Linkesch, M Weissel

    Publicado 1992
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment

    Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment por Heinz Gisslinger, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva, Miklós Egyed, Petr Ďulíček, Árpád Illés, Halyna Pylypenko, Lylia Sivcheva, Jiřı́ Mayer, Vera Yablokova, Kurt Krejcy, Victoria Empson, Hans Carl Hasselbalch, Róbert Královics, Jean‐Jacques Kiladjian, Heinz Gisslinger, Jean‐Jacques Kiladjian

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Carta
    Engadir a favoritos
    Gardado en:
  8. 8
    Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial

    Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial por Heinz Gisslinger, Mirjana Gotić, Jerzy Hołowiecki, Miroslav Penka, Jüergen Thiele, Hans Michael Kvasnicka, Róbert Královics, Petro E. Petrides

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion

    The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion por Tiziano Barbui, Jürgen Thiele, Heinz Gisslinger, Hans Michael Kvasnicka, Alessandro M. Vannucchi, Paola Guglielmelli, Attilio Orazi, Ayalew Tefferi

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  10. 10
    Long non-coding RNAs display higher natural expression variation than protein-coding genes in healthy humans

    Long non-coding RNAs display higher natural expression variation than protein-coding genes in healthy humans por Aleksandra E. Kornienko, Christoph Dotter, Philipp Guenzl, Heinz Gisslinger, Bettina Gisslinger, Ciara Cleary, Róbert Královics, Florian M. Pauler, Denise P. Barlow

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia

    Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia por Marco Ruggeri, Heinz Gisslinger, Alberto Tosetto, C. Rintelen, Christine Mannhalter, Ingrid Pabinger, Navide Heis, Giancarlo Castaman, Edoardo Missiaglia, Klaus Lechner, Francesco Rodeghiero

    Publicado 2002
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617F

    Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617F por Franz X. Schaub, Roland Jäger, Renate Looser, Hui Hao-Shen, Sylvie Hermouet, François Girodon, André Tichelli, Heinz Gisslinger, Róbert Královics, Radek C. Skoda

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma

    Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma por H. Ludwig, Zdeněk Adam, E Tóthová, Roman Hájek, Boris Labar, Miklós Egyed, Ivan Špıčka, Heinz Gisslinger, Johannes Drach, Ingrid Kühn, Axel Hinke, N. Zojer

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders

    Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders por Daniela Pietra, Sai Li, Angela Brisci, Francesco Passamonti, Elisa Rumi, Alexandre Theocharides, Maurizio Ferrari, Heinz Gisslinger, Róbert Královics, Laura Cremonesi, Radek C. Skoda, Mario Cazzola

    Publicado 2007
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma

    Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma por Heinz Ludwig, Roman Hájek, Elena Tóthová, Johannes Drach, Zdeněk Adam, Boris Labar, Miklós Egyed, Ivan Špıčka, Heinz Gisslinger, Richard Greil, Ingrid Kühn, Niklas Zojer, Axel Hinke

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Light Chain–Induced Acute Renal Failure Can Be Reversed by Bortezomib-Doxorubicin-Dexamethasone in Multiple Myeloma: Results of a Phase II Study

    Light Chain–Induced Acute Renal Failure Can Be Reversed by Bortezomib-Doxorubicin-Dexamethasone in Multiple Myeloma: Results of a Phase II Study por Heinz Ludwig, Zdeněk Adam, Roman Hájek, Richard Greil, Elena Tóthová, Felix Keil, Eva Maria Autzinger, Josef Thaler, Heinz Gisslinger, Alois Lang, Miklós Egyed, Irene Womastek, Niklas Zojer

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    EXPAND, a dose-finding study of ruxolitinib in patients with myelofibrosis and low platelet counts: 48-week follow-up analysis

    EXPAND, a dose-finding study of ruxolitinib in patients with myelofibrosis and low platelet counts: 48-week follow-up analysis por Alessandro M. Vannucchi, Peter te Boekhorst, Claire Harrison, Guangsheng He, Marianna Caramella, Dietger Niederwieser, Françoise Boyer‐Perrard, Minghui Duan, Nathalie Francillard, Betty Molloy, Monika Wroclawska, Heinz Gisslinger

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b

    Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b por Jean‐Jacques Kiladjian, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva, Miklós Egyed, Petr Ďulíček, Árpád Illés, Halyna Pylypenko, Lylia Sivcheva, Jiřı́ Mayer, Vera Yablokova, Kurt Krejcy, Victoria Empson, Hans Carl Hasselbalch, Róbert Královics, Heinz Gisslinger, Jean‐Jacques Kiladjian, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva, Miklós Egyed, Petr Ďulíček, Árpád Illés, Halyna Pylypenko, Lylia Sivcheva, Jiřı́ Mayer, Vera Yablokova, Heinz Gisslinger

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Carta
    Engadir a favoritos
    Gardado en:
  19. 19
    Masked polycythemia vera diagnosed according to WHO and BCSH classification

    Masked polycythemia vera diagnosed according to WHO and BCSH classification por Tiziano Barbui, Jürgen Thiele, Alessandra Carobbio, Heinz Gisslinger, Guido Finazzi, Elisa Rumi, Maria Luigia Randi, Alessandro M. Vannucchi, Bettina Gisslinger, Leonhard Müllauer, Marco Ruggeri, Alessandro Rambaldi, Ayalew Tefferi

    Publicado 2013
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group

    A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group por Giovanni Barosi, Carlos Besses, Gunnar Birgegård, J Brière, Francisco Cervantes, Guido Finazzi, Heinz Gisslinger, Martin Grießhammer, L Gugliotta, Claire Harrison, Hans Carl Hasselbalch, Eva Lengfelder, John T. Reilly, Jan Michiels, Tiziano Barbui

    Publicado 2006
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: